Alternative management of central serous chorioretinopathy using intravitreal metoprolol.
Annelise Nicotti GonçalvesIngrid U ScottRodrigo JorgePublished in: International journal of retina and vitreous (2022)
These preliminary findings suggest that intravitreal metoprolol may be a safe alternative therapy for patients with cCSC.